Work

Clonal Suppression of TP53 Mutant MDS and Oligoblastic AML with Hypomethylating Agent Therapy Improves Overall Survival

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-117297

Authors: David A Sallman, Najla Al Ali, Seongseok Yun, Eric Padron, Jinming Song, Mohammad Omar Hussaini, Chetasi Talati, Kendra L. Sweet, Jeffrey E. Lancet, Alan F. List, Rami S. Komrokji

Institution: Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907073897

Cites:

Cited by: 12

Related to: 10